Published in Lymphokine Res on January 01, 1982
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22
Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell (1990) 5.73
Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol (1968) 4.66
Organization and evolution of the class I gene family in the major histocompatibility complex of the C57BL/10 mouse. Nature (1984) 4.22
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol (1987) 2.08
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Homograft target cells: contact destruction in vitro by immune macrophages. Science (1966) 1.77
The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages. Cell Immunol (1972) 1.73
Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction. J Immunol (1969) 1.60
Lymphocyte in vitro cytotoxicity: correlation of derepression with release of lymphotoxin from human lymphocytes. J Immunol (1969) 1.53
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. J Immunol (1970) 1.43
Secretion of a soluble class I molecule encoded by the Q10 gene of the C57BL/10 mouse. EMBO J (1985) 1.40
The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol (1978) 1.40
Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature (1968) 1.39
Duplicated gene pairs and alleles of class I genes in the Qa2 region of the murine major histocompatibility complex: a comparison. EMBO J (1985) 1.36
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A (1990) 1.34
Genetic variants associated with deep vein thrombosis: the F11 locus. J Thromb Haemost (2009) 1.24
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes. J Immunol (1975) 1.24
Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1. J Natl Cancer Inst (1985) 1.16
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res (1993) 1.14
An improved in vitro assay for lymphotoxin. Cell Immunol (1972) 1.14
Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J Natl Cancer Inst (1972) 1.14
Human pro-tumor necrosis factor is a homotrimer. Biochemistry (1996) 1.12
Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin. Cell Immunol (1970) 1.12
Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro. J Biol Response Mod (1984) 1.10
Studies on in vitro models of cellular immunity: the role of T and B cells in the secretion of lymphotoxin. Cell Immunol (1973) 1.09
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci U S A (2000) 1.08
Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin. J Immunol (1974) 1.07
The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line. J Immunol (1986) 1.05
The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol (1991) 1.05
The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. J Immunol (1986) 1.01
Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw (1993) 1.00
Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction. Proc Natl Acad Sci U S A (1973) 0.98
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. J Clin Immunol (1987) 0.98
Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. J Immunother (1991) (1991) 0.97
Lack of class I H-2 antigens in cells transformed by radiation leukemia virus is associated with methylation and rearrangement of H-2 DNA. Proc Natl Acad Sci U S A (1986) 0.96
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol (1996) 0.95
On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. Cancer Res (1972) 0.95
Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane. J Natl Cancer Inst (1973) 0.94
Chronic administration of hydroxylamine and derivatives in mice. Proc Soc Exp Biol Med (1967) 0.94
Tolerance to endotoxin in vitro: independent regulation of interleukin-1, tumor necrosis factor and interferon alpha production during in vitro differentiation of human monocytes. Lymphokine Res (1990) 0.94
Effect of dietary riboflavin on azo dye reductase in liver and in bacteria of cecal contents of rats. Biochem Pharmacol (1970) 0.94
Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing. Biochemistry (1996) 0.93
Regulation of growth of human diploid fibroblasts by factors elaborated by activated lymphoid cells. J Cell Physiol (1982) 0.93
Antioxidants and carcinogenesis: butylated hydroxytoluene, but not diphenyl-p-phenylenediamine, inhibits cancer induction by N-2-fluorenylacetamide and by N-hydroxy-N-2-fluorenylacetamide in rats. Food Cosmet Toxicol (1973) 0.92
Mechanisms of lymphocyte-induced cell and tissue destruction in vitro. Am J Pathol (1970) 0.92
Lymphocyte effector molecules and cell-mediated immune reactions. Contemp Top Mol Immunol (1975) 0.91
Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat. Am J Pathol (1987) 0.91
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium. Clin Toxicol (Phila) (2013) 0.91
Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. J Immunol (1984) 0.91
Modulation of TNF-alpha-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors. Arch Biochem Biophys (1992) 0.91
Variants of the receptor/channel clustering molecule gephyrin in brain: distinct distribution patterns, developmental profiles, and proteolytic cleavage by calpain. J Neurosci Res (1997) 0.90
8-hydroxyquinoline: chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol Appl Pharmacol (1971) 0.90
Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg (1994) 0.89
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell line. Cancer Chemother Pharmacol (2000) 0.89
Cellulose dietary bulk and azoxymethane-induced intestinal cancer. J Natl Cancer Inst (1973) 0.89
Effects of pituitary hormones and prefeeding N-hydroxy-N-2-fluorenylacetamide on the metabolism of this carcinogen and on physiologic parameters. Cancer Res (1966) 0.89
Lymphokines--the mediators of cellular immunity. Ser Haematol (1972) 0.88
Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma. J Interferon Cytokine Res (1995) 0.88
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum (1989) 0.88
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide. Leuk Res (1999) 0.87
Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol (1993) 0.87
Arginine as a contact residue in the hapten-binding site of protein 315. Immunochemistry (1977) 0.87
Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction. Cell Immunol (1973) 0.87
The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte. Cell Immunol (1975) 0.87
Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro. J Immunol (1981) 0.87
Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J Immunol (1993) 0.86
Ornithine decarboxylase induction and polyamine levels in the kidney of estradiol-treated castrated male rats. Life Sci (1980) 0.86
In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cell Immunol (1976) 0.86
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. Lymphokine Res (1990) 0.85
Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery (1990) 0.85
Human pro-tumor necrosis factor: molecular determinants of membrane translocation, sorting, and maturation. Mol Cell Biol (1995) 0.85
Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin. J Immunol (1986) 0.85
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines. J Clin Invest (1989) 0.85
The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene (1996) 0.84
Absence of lysine from the DNP-lysine binding site of protein 315; designation of lysine 52 of the heavy chain as a peripheral residue. Immunochemistry (1977) 0.84
Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Cell Immunol (1996) 0.84
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancers. Int J Cancer (1996) 0.84
Gene variants associated with venous thrombosis: confirmation in the MEGA study. J Thromb Haemost (2010) 0.84
Lymphotoxin detected in the blister fluid of bullous pemphigoid patients. J Clin Immunol (1984) 0.83
Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells. Prostate (2007) 0.83
Production of granulocyte colony-stimulating factor by a human melanoma cell line. Exp Hematol (1987) 0.83
Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma. J Cell Biochem (1988) 0.83
Rapid, quantitative microassay for the monokine respiration inhibitory factor. J Immunol Methods (1987) 0.83